Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-037474
Filing Date
2025-12-10
Accepted
2025-12-10 21:54:29
Documents
1
Period of Report
2025-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 7222
  Complete submission text file 0001437749-25-037474.txt   8910
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Issuer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O BIOCARDIA, INC. 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address
McClung David (Reporting) CIK: 0001686155 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38999 | Film No.: 251563378